Cognitive and neuropsychiatric disease manifestations in MS

Multiple Sclerosis and Related Disorders

Volumn 2, Issue 1, 2013, Pages 4-12

  Feinstein, A ^a   Deluca, J ^b   Baune, B T ^c   Filippi, M ^d   Lassman, H ^e  

^a UNIVERSITY OF TORONTO   (Canada)

^b KESSLER FOUNDATION   (United States)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e Medical University of Vienna   (Austria)

Author keywords

Cognition; Depression; MRI; Multiple sclerosis; Neuropathology; Neuropsychiatry

Indexed keywords

ALEMTUZUMAB; ANTIDEPRESSANT AGENT; BETA INTERFERON; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; DEXTROMETHORPHAN; FINGOLIMOD; GLATIRAMER; INTERLEUKIN 1; INTERLEUKIN 6; LITHIUM CARBONATE; MITOXANTRONE; NATALIZUMAB; NEUROLEPTIC AGENT; QUINIDINE; RITUXIMAB; SEROTONIN UPTAKE INHIBITOR; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ALZHEIMER DISEASE; ANHEDONIA; ANXIETY DISORDER; BIPOLAR DISORDER; BRAIN FUNCTION; BRAIN RADIOGRAPHY; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; COGNITIVE DEFECT; COGNITIVE THERAPY; DISEASE SEVERITY; DRUG MEGADOSE; DYSPHORIA; ELECTROCONVULSIVE THERAPY; FATIGUE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMMUNOTHERAPY; LOW DRUG DOSE; MAJOR DEPRESSION; MENTAL HEALTH CARE PERSONNEL; MENTAL TASK; MOLECULAR PATHOLOGY; MOTOR RETARDATION; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROPATHOLOGY; NEUROPROTECTION; NEUROPSYCHIATRY; NONHUMAN; PATHOLOGICAL CRYING; PATHOLOGICAL LAUGHTER; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSYCHOSIS; REVIEW; RNA VIRUS INFECTION; SEVERE COMBINED IMMUNODEFICIENCY; SLEEP DISORDER; TASK PERFORMANCE; WEIGHT REDUCTION;

EID: 84866677864     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2012.08.001     Document Type: Review

References (96)

1. M.P. Amato, M.L. Bartolozzi, V. Zipoli, E. Portaccio, M. Mortilla, and L. Guidi Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment Neurology 63 2004 89 93
2. M.P. Amato, E. Portaccio, B. Goretti, V. Zipoli, M. Battaglini, and M.L. Bartolozzi Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis Archives of Neurology 64 2007 1157 1161
3. P.A. Arnett, S. Rao, L. Bernardin, J. Grafman, F.Z. Yetkin, and L. Lobeck Relationship between frontal lobe lesions and Wisconsin card sorting test performance in patients with multiple sclerosis Neurology 44 1994 420 425
4. P.A. Arnett, C.I. Higginson, W.D. Voss, B. Wright, W.I. Bender, and J.M. Wurst Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning Neuropsychology 13 1999 434 446
5. R. Bakshi, D. Czarnecki, Z.A. Shaikh, R.L. Priore, V. Janardhan, and Z. Kaliszky Brain MRI lesions and atrophy are related to depression in multiple sclerosis Neuroreport 11 2000 1153 1158
6. M.H. Barnett, and J.W. Prineas Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion Annals of Neurology 55 2004 458 468
7. Baune BT. Depression and cytokine-regulated pathways. In: Lopez-Munoz F, Alamo C. editors. Neurobiology of depression. Taylor & Francis Group: New York, p. 293-316, (in press).
8. A.T. Beck, R.A. Steer, and G.K. Brown BDI-fast screen for medical patients 2007 The Psychological Corporation
9. R. Benedict, M.P. Amato, J. Boringa, B. Brochet, and F. Foley Brief International Cognitive Assessment for MS (BICAMS): international standards for validation BMC Neurology 12 1 2012 55 [Epub ahead of print]
10. R.H. Benedict, I. Fishman, M.M. McClellan, R. Bakshi, and B. Weinstock-Guttman Validity of the beck depression inventory-fast screen in multiple sclerosis Multiple Sclerosis 9 2003 393 396
11. R.H. Benedict, and R. Zivadinov Risk factors for and management of cognitive dysfunction in multiple sclerosis Nature Reviews Neurology 7 6 2011 332 342
12. D. Berg, T. Supprian, J. Thomae, M. Warmuth-Metz, A. Horowski, and B. Zeiler Lesion pattern in patients with multiple sclerosis and depression Multiple Sclerosis 6 2000 56 162
13. C. Bjartmar, G. Kidd, S. Mork, R. Rudick, and B.D. Trapp Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients Annals of Neurology 48 2000 893 901
14. S. Bramow, J.M. Frischer, H. Lassmann, N. Koch-Henriksen, C.F. Lucchinetti, and P.S. Sorensen Demyelination versus remyelination in progressive multiple sclerosis Brain 133 2010 2983 2998
15. S.D. Brass, R.H. Benedict, B. Weinstock-Guttman, F. Munschauer, and R. Bakshi Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis Multiple Sclerosis 12 4 2006 437 444
16. L. Capuron, and A. Ravaud Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state New England Journal of Medicine 340 17 1999 1370
17. M. Catena-Dell'Osso, C. Bellantuono, G. Consoli, S. Baroni, F. Rotella, and D. Marazziti Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Current Medicinal Chemistry 18 2 2011 245 255
18. e ed. Paris; 1880.
19. N.D. Chiaravalloti, J. DeLuca, N.B. Moore, and J.H. Ricker Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial Multiple Sclerosis 11 2005 58 68
20. N.D. Chiaravalloti, and J. DeLuca Cognitive impairment in multiple sclerosis Lancet Neurology 7 2008 1139 1151
21. A. Cifelli, M. Arridge, P. Jezzard, M.M. Esiri, and J. Palace Thalamic neurodegeneration in multiple sclerosis Annals of Neurology 52 2002 650 653
22. S.S. Cottrell, and S.A.K. Wilson The affective symptomatology of disseminated sclerosis Journal of Neurological Psychopathology 7 1926 1 30
23. S. D'Alisa, G. Miscio, S. Baudo, A. Simone, L. Tesio, and A. Mauro Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study Disability and Rehabilitation 28 2006 307 314
24. J. DeLuca, S. Barbieri-Berger, and S.K. Johnson The nature of memory impairments in multiple sclerosis: acquisition versus retrieval Journal of Clinical and Experimental Neuropsychology 16 2 1994 183 189
25. R.A. Dineen, J. Vilisaar, J. Hlinka, C.M. Bradshaw, P.S. Morgan, and C.S. Constantinescu Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis Brain 132 2009 239 249
26. D.M. Ehde, G.H. Kraft, L. Chwastiak, M.D. Sullivan, L.E. Gibbons, and C.H. Bombardier Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis General Hospital Psychiatry 30 1 2008 40 48
27. R.A. Farrell, D. Antony, G.R. Wall, D.A. Clark, L. Fisniku, and J. Swanton Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI Neurology 73 2009 32 38
28. A. Feinstein, K.J. Feinstein, T. Gray, and P. O'Connor Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis Archives of Neurology 54 9 1997 1116 1121
29. A. Feinstein Multiple sclerosis and suicidal intent Neurology 59 2002 674 678
30. A. Feinstein The clinical neuropsychiatry of multiple sclerosis 2nd Edition 2007 Cambridge University Press Cambridge, UK
31. A. Feinstein, P. Roy, N. Lobaugh, K. Feinstein, P. O'Connor, and S. Black Structural brain abnormalities in multiple sclerosis patients with major depression Neurology 62 4 2004 586 590
32. A. Feinstein, P. O'Connor, N. Akbar, L. Moradzadeh, C.J. Scott, and N.J. Lobaugh Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients Multiple Sclerosis 16 2010 189 196
33. M. Filippi, C. Tortorella, M. Rovaris, M. Bozzali, F. Possa, and M.P. Sormani Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis Journal of Neurology, Neurosurgery and Psychiatry 68 2000 157 161
34. I. Fishman, R.H.B. Benedict, R. Bakshi, R. Priore, and B. Weinstock-Guttman Construct validity and frequency of euphoria sclerotica in multiple sclerosis Journal of Neuropsychiatry and Clinical Neurosciences 16 2004 350 356
35. J.M. Fletcher, S.J. Lalor, C.M. Sweeney, N. Tubridy, and K.H. Mills T cells in multiple sclerosis and experimental autoimmune encephalomyelitis Clinical and Experimental Immunology 162 1 2010 1 11
36. J.M. Frischer, S. Bramow, A. Dal Bianco, C. Lucchinetti, and H. Rauschka The relation between inflammation and neurodegeneration in multiple sclerosis Brain 132 2009 1175 1189
37. J.J. Geurts, and F. Barkhof Grey matter pathology in multiple sclerosis Lancet Neurology 7 2008 841 851
38. P.S. Giacomini, P.J. Darlington, and A. Bar-Or Emerging multiple sclerosis disease-modifying therapies Current Opinion in Neurology 22 2009 226 232
39. S.M. Gold, K.C. Kern, M.F. O'Connor, M.J. Montag, A. Kim, and Y.S. Yoo Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms Biological Psychiatry 68 2010 553 559
40. S.M. Gold, S. Kruger, K.J. Ziegler, T. Krieger, K.H. Schulz, and C. Otte Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression Journal of Neurology Neurosurgery and Psychiatry 82 7 2011 814 818
41. Y. Goverover, N.D. Chiaravalloti, and J. DeLuca Self-generation to improve learning and memory of functional activities in multiple sclerosis: meal preparation and managing finances Archives of Physical Medicine and Rehabilitation 89 2008 1514 1521
42. Y. Goverover, M.R. Basso, H. Wood, N. Chiaravalloti, and J. DeLuca Examining the benefits of combining two learning strategies on recall of functional information in persons with multiple sclerosis Multiple Sclerosis 17 12 2011 1488 1497
43. S. Hochmeister, R. Grundtner, J. Bauer, B. Engelhardt, R. Lyck, and G. Gordon Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis Journal of Neuropathology and Experimental Neurology 65 2006 855 865
44. R. Hohlfeld, and H. Wekerle Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines Proceedings of the National Academy of Sciences USA Suppl 2 2004 14599 14606 101 Suppl 2 2004 14599 14606
45. K. Honarmand, and A. Feinstein Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients Multiple Sclerosis 15 2009 1518 1524
46. M.K. Houtchens, R.H. Benedict, R. Killiany, J. Sharma, Z. Jaisani, and B. Singh Thalamic atrophy and cognition in multiple sclerosis Neurology 69 2007 1213 1223
47. G. Ingram, S. Hakobyan, C.L. Hirst, C.L. Harris, T.P. Pickersgill, and M.D. Cossburn Complement regulator factor H as a serum biomarker of multiple sclerosis disease state Brain 133 Pt 6 2010 1602 1611
48. International Multiple Sclerosis Genetics Consortium (IMSGC) Evidence for polygenic susceptibility to multiple sclerosis - the shape of things to come American Journal of Human Genetics 86 2010 621 625
49. J. Kipnis, H. Cohen, M. Cardon, Y. Ziv, and M. Schwartz T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions Proceedings of the National Academy of Sciences USA 101 21 2004 8180 8185
50. M. Korostil, and A. Feinstein Anxiety disorders in patients with multiple sclerosis Multiple Sclerosis 13 2007 67 72
51. A. Kutzelnigg, C.F. Lucchinetti, C. Stadelmann, W. Bruck, H. Rauschka, and M. Bergmann Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 128 2005 2705 2712
52. A. Kutzelnigg, and H. Lassmann Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits? Journal of the Neurological Sciences 245 2006 123 126
53. H. Lassmann, W. Brück, and C. Lucchinetti The immunopathology of multiple sclerosis: an overview Brain Pathology 17 2007 210 218
54. H. Lassmann Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease Journal of Neural Transmission 118 5 2011 747 752
55. H. Lassmann, and J. van Horssen The molecular basis of neurodegeneration in multiple sclerosis FEBS 2011 Let epub ahead of print
56. F.D. Lublin, and S.C. Reingold Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multliple sclerosis Neurology 46 1996 907 911
57. C. Lucchinetti, W. Brück, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination Annals of Neurology 47 2000 707 717
58. A. Lutterotti, and R. Martin Getting specific: monoclonal antibodies in multiple sclerosis Lancet Neurology 7 2008 538 547
59. C. Mainero, F. Caramia, C. Pozzilli, A. Pisani, I. Pestalozza, and G. Borriello fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis Neuroimage 21 2004 858 867
60. G. Mattingley, K. Baker, C.F. Zorumski, and G.S. Figiel Multiple sclerosis and ECT: possible value of gadolinium enhanced magnetic resonance scans for identifying high risk patients Journal of Neuropsychiatry and Clinical Neurosciences 4 1992 145 151
61. J. McAfoose, and B.T. Baune Evidence for a cytokine model of cognitive function Neuroscience and Biobehavioral Reviews 33 3 2009 355 366
62. E.M. McDonald, A.H. Mann, and H.C. Thomas Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers Lancet 2 8569 1987 1175 1178
63. D.C. Mohr, A.C. Boudewyn, D.E. Goodkin, A. Bostrom, and L. Epstein Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis Journal of Consulting and Clinical Psychology 69 2001 942 949
64. A.R. O'Brien, N. Chiaravalloti, Y. Goverover, and J. DeLuca Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature Archives of Physical Medicine and Rehabilitation 89 2008 761 769
65. D.T. Okuda, R. Srinivasan, J.R. Oksenberg, D.S. Goodin, S.E. Baranzini, and A. Beheshtian Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures Brain 132 Pt 1 2009 250 259
66. H.S. Panitch, F.R.A. Thisted, R.A. Smith, D.R. Wynn, and J.P. Wymer Randomized, controled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis Annals of Neurology 59 2006 780 787
67. L. Passamonti, A. Cerasa, M. Liguori, M.C. Gioia, P. Valentino, and R. Nistico Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis Brain 132 2009 3380 3391
68. S.B. Patten, C.A. Beck, J.V.A. Williams, C. Barbui, and L.M. Metz Major depression in multiple sclerosis. A population-based perspective Neurology 61 2003 1524 1527
69. S.B. Patten, L.W. Svenson, and L.M. Metz Psychotic disorders in MS: population-based evidence of an association Neurology 65 2005 1123 1125
70. I.K. Penner, M. Rausch, L. Kappos, K. Opwis, and E.W. Radu Analysis of impairment related functional architecture in MS patients during performance of different attention tasks Journal of Neurology 250 2003 461 472
71. S. Penny, Z. Khaleeli, L. Cipolotti, A. Thompson, and M. Ron Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis Neurology 74 2010 545 552
72. J. Pujol, J. Bello, J. Deus, J.L. Marti-Vilalta, and A. Capdevila Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis Neurology 49 1997 1105 1110
73. S. Quesnel, and A. Feinstein Alcohol and multiple sclerosis: a study of problem drinking Multiple Sclerosis 10 2004 197 201
74. P.V. Rabins, B.R. Brooks, P. O'Donnell, G.D. Pearlson, and P. Moberg Structural brain correlates of emotional disorders in multiple sclerosis Brain 109 1986 585 597
75. S.M. Rao, G.J. Leo, V.M. Haughton St, P. Aubin-Faubert, and L. Bernardin Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis Neurology 39 1989 161 166
76. G. Riccitelli, M.A. Rocca, E. Pagani, M.E. Rodegher, P. Rossi, and A. Falini Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype Human Brain Mapping 32 2011 1535 1543
77. M.A. Rocca, P. Valsasina, M. Absinta, G. Riccitelli, M.E. Rodegher, and P. Misci Default-mode network dysfunction and cognitive impairment in progressive MS Neurology 74 2010 1252 1259
78. S.D. Roosendaal, J.J. Geurts, H. Vrenken, H.E. Hulst, K.S. Cover, and J.A. Castelijns Regional DTI differences in multiple sclerosis patients Neuroimage 44 2009 1397 1403
79. S.D. Roosendaal, B. Moraal, P.J. Pouwels, H. Vrenken, J.A. Castelijns, and F. Barkhof Accumulation of cortical lesions in MS: relation with cognitive impairment Multiple Sclerosis 15 2009 708 714
80. D.L. Rosenstein, D. Lerner, and J. Cai More on the depressive effects of interferon alfa New England Journal of Medicine 341 11 1999 849 850
81. M. Rovaris, G. Comi, and M. Filippi MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction Journal of the Neurological Sciences 245 2006 111 116
82. A.D. Sadovnick, R.A. Remick, J. Allen, E. Swartz, I.M. Yee, and K. Eisen Depression and multiple sclerosis Neurology 46 1996 628 632
83. E.N. Stenager, E. Stenager, N. Koch-Henrikson, H. Bronnum-Hansen, K. Hyllested, and K. Jensen Suicide and multiple sclerosis: an epidemiological investigation Journal of Neurology and Psychiatry 55 1992 542 545
84. B. Serafini, B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis Brain Pathology 14 2004 164 174
85. M.K. Sharief, and R. Hentges Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis New England Journal of Medicine 325 7 1991 467 472
86. C. Stadelmann Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications Current Opinion in Neurology 24 3 2011 224 229
87. L. Strober, J. Englert, F. Munschauer, B. Weinstock-Guttman, S. Rao, and R.H. Benedict Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao brief repeatable neuropsychological battery and the minimal assessment of cognitive function in MS Multiple Sclerosis 15 2009 1077 1084
88. J.F. Sumowski, G.R. Wylie, N.D. Chiaravalloti, and J. DeLuca Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis Neurology 74 24 2010 1942 1945
89. J.F. Sumowski, N. Chiaravalloti, and J. DeLuca Retrieval practice improves memory in multiple sclerosis: clinical application of the testing effect Neuropsychology 24 2010 267 272
90. J.F. Sumowski, G.R. Wylie, J. DeLuca, and N. Chiaravalloti Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve Brain 133 2010 362 374
91. T. Swirsky-Sacchetti, D.R. Mitchell, J. Seward, C. Gonzales, F Lublin, and R Knobler Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis Neurology 42 1992 1291 1295
92. C.E. Teunissen, C. Dijkstra, and C. Polman Biological markers in CSF and blood for axonal degeneration in multiple sclerosis Lancet Neurology 4 1 2005 32 41
93. B.D. Trapp, and K.A. Nave Multiple sclerosis: an immune or neurodegenerative disorder? Annual Review of Neuroscience 31 2008 247 2696
94. M. Vercellino, S. Masera, M. Lorenzatti, C. Condello, and A. Merola Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep grey matter Journal of Neuropathology and Experimental Neurology 68 2009 489 502
95. H. Wiendl, and R. Hohlfeld Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes Neurology 72 2009 1008 1015
96. A.S. Zigmond, and R.P. Snaith The hospital anxiety and depression scale Acta Psychiatrica Scandinavica 67 1983 361 370